AXGT

Axovant Gene Therapies Ltd.CIK 1636050 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for AXGT PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for AXGT

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Vuori Kristiina MD	Director	1	$0	$0	2020-10-05
Cheruvu Pavan	Principal Executive Officer	10	$141.8K	$0	2020-07-08
Pande Atul	Director	5	$62.7K	$0	2020-07-08
Corcoran Gavin	EVP of R&D	8	$0	$0	2020-06-12
Nassif David W.	Principal Financial Officer	8	$0	$0	2020-06-12
Sundaram Senthil Vel	Director	2	$0	$0	2020-04-15
Torti Frank	Director	2	$0	$0	2020-04-15
Modig Berndt	Director	2	$0	$0	2020-04-15
Roivant Sciences Ltd.	10% Owner	1	$20.00M	$0	2020-02-24
Bazley Mathew C.	General Counsel	2	$0	$0	2019-04-15
Bickerstaff George	Director	1	$0	$0	2019-04-15
JEFFS ROGER	Director	1	$0	$0	2019-04-15
POTTER MYRTLE S	Director	1	$0	$0	2019-04-15

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Vuori Kristiina MD	Director	A Award deriv	2020-10-05	2020-10-07	35,000	—	$0	35,000	SEC↗
Cheruvu Pavan	Principal Executive Officer	P Buy	2020-07-08	2020-07-10	37,500	$2.74	$102.8K	57,836	SEC↗
Pande Atul	Director	P Buy	2020-07-08	2020-07-10	10,000	$2.73	$27.3K	23,370	SEC↗
Corcoran Gavin	Chief R&D Officer	D To issuer deriv	2020-06-12	2020-06-15	16,002	—	$0	16,001	SEC↗
Nassif David W.	Principal Financial Officer	D To issuer deriv	2020-06-12	2020-06-15	15,060	—	$0	15,060	SEC↗
Corcoran Gavin	Chief R&D Officer	A Award	2020-06-12	2020-06-15	16,002	—	$0	16,002	SEC↗
Corcoran Gavin	Chief R&D Officer	F Tax w/h	2020-06-12	2020-06-15	6,211	$3.46	$21.5K	9,791	SEC↗
Cheruvu Pavan	Principal Executive Officer	D To issuer deriv	2020-06-11	2020-06-15	22,591	—	$0	22,590	SEC↗
Cheruvu Pavan	Principal Executive Officer	F Tax w/h	2020-06-11	2020-06-15	9,755	$3.09	$30.1K	20,336	SEC↗
Cheruvu Pavan	Principal Executive Officer	A Award	2020-06-11	2020-06-15	22,591	—	$0	30,091	SEC↗
Nassif David W.	Principal Financial Officer	A Award	2020-06-11	2020-06-15	15,060	—	$0	24,210	SEC↗
Nassif David W.	Principal Financial Officer	F Tax w/h	2020-06-11	2020-06-15	5,266	$3.25	$17.1K	18,944	SEC↗
Cheruvu Pavan	Principal Executive Officer	A Award deriv	2020-04-15	2020-04-17	112,700	—	$0	112,700	SEC↗
Cheruvu Pavan	Principal Executive Officer	A Award deriv	2020-04-15	2020-04-17	169,100	—	$0	169,100	SEC↗
Nassif David W.	Principal Financial Officer	A Award deriv	2020-04-15	2020-04-17	78,900	—	$0	78,900	SEC↗
Nassif David W.	Principal Financial Officer	A Award deriv	2020-04-15	2020-04-17	52,600	—	$0	52,600	SEC↗
Corcoran Gavin	EVP of R&D	A Award deriv	2020-04-15	2020-04-17	63,700	—	$0	63,700	SEC↗
Corcoran Gavin	EVP of R&D	A Award deriv	2020-04-15	2020-04-17	42,400	—	$0	42,400	SEC↗
Sundaram Senthil Vel	Director	A Award deriv	2020-04-15	2020-04-17	17,500	—	$0	17,500	SEC↗
Torti Frank	Director	A Award deriv	2020-04-15	2020-04-17	17,500	—	$0	17,500	SEC↗
Pande Atul	Director	A Award deriv	2020-04-15	2020-04-17	17,500	—	$0	17,500	SEC↗
Modig Berndt	Director	A Award deriv	2020-04-15	2020-04-17	17,500	—	$0	17,500	SEC↗
Pande Atul	Director	P Buy	2020-03-16	2020-03-18	10,000	$1.78	$17.8K	13,370	SEC↗
Roivant Sciences Ltd.	10% Owner	P Buy	2020-02-24	2020-02-27	5,333,333	$3.75	$20.00M	18,577,380	SEC↗
Cheruvu Pavan	Principal Executive Officer	A Award deriv	2019-09-21	2019-09-24	45,181	—	$0	45,181	SEC↗
Nassif David W.	Principal Financial Officer	A Award deriv	2019-09-21	2019-09-24	30,120	—	$0	30,120	SEC↗
Corcoran Gavin	EVP of R&D	A Award deriv	2019-09-21	2019-09-24	32,003	—	$0	32,003	SEC↗
Nassif David W.	Principal Financial Officer	A Award deriv	2019-07-01	2019-07-02	75,000	—	$0	75,000	SEC↗
Nassif David W.	Principal Financial Officer	A Award deriv	2019-07-01	2019-07-02	150,000	—	$0	150,000	SEC↗
Sundaram Senthil Vel	Director	A Award deriv	2019-06-27	2019-07-01	18,750	—	$0	18,750	SEC↗
Pande Atul	Director	P Buy	2019-06-14	2019-06-17	3,370	$5.22	$17.6K	3,370	SEC↗
Cheruvu Pavan	Chief Executive Officer	P Buy	2019-06-14	2019-06-17	7,500	$5.21	$39.1K	7,500	SEC↗
JEFFS ROGER	Director	A Award deriv	2019-04-15	2019-04-17	255,000	—	$0	255,000	SEC↗
Bazley Mathew C.	General Counsel	A Award deriv	2019-04-15	2019-04-17	250,000	—	$0	250,000	SEC↗
Bazley Mathew C.	General Counsel	A Award deriv	2019-04-15	2019-04-17	726,000	—	$0	726,000	SEC↗
Cheruvu Pavan	Chief Executive Officer	A Award deriv	2019-04-15	2019-04-17	1,596,000	—	$0	1,596,000	SEC↗
Cheruvu Pavan	Chief Executive Officer	A Award deriv	2019-04-15	2019-04-17	1,596,000	—	$0	1,596,000	SEC↗
Modig Berndt	Director	A Award deriv	2019-04-15	2019-04-17	255,000	—	$0	255,000	SEC↗
Corcoran Gavin	EVP of R&D	A Award deriv	2019-04-15	2019-04-17	200,000	—	$0	200,000	SEC↗
Corcoran Gavin	EVP of R&D	A Award deriv	2019-04-15	2019-04-17	767,000	—	$0	767,000	SEC↗
Torti Frank	Director	A Award deriv	2019-04-15	2019-04-17	255,000	—	$0	255,000	SEC↗
POTTER MYRTLE S	Director	A Award deriv	2019-04-15	2019-04-17	255,000	—	$0	255,000	SEC↗
Bickerstaff George	Director	A Award deriv	2019-04-15	2019-04-17	255,000	—	$0	255,000	SEC↗
Pande Atul	Director	A Award deriv	2019-04-15	2019-04-17	255,000	—	$0	255,000	SEC↗